greeksoup/ stock research
Stock research / United States / Funds / Hhlr Advisors, Ltd

Hhlr Advisors, Ltd

CIK 1762304 · latest 13F filed 14 August 2026 · Read the filing on EDGAR

Hhlr Advisors, Ltd reported 35 US-listed holdings worth $832.1 million in its 13F for the quarter ended 30 June 2026, filed 14 August 2026. Its largest: Legend Biotech Corp. (20.8%), Futu Hldgs Ltd (19.9%) and Arrivent Biopharma Inc. (16.4%). Against the quarter before, it opened 6 positions, added to 6, trimmed 6 and sold out of 9.

Reported holdings$832.1M-50.3% on Q1 2026
Positions35-3 on Q1 2026
The largest ten85.7%of its reported holdings
Latest 13FQ2 2026filed 14 August 2026
Where the money is
OpenedAdded toHeldTrimmed
LEGN20.8%FUTU19.9%AVBP16.4%MRVL5.8%VIPS5.5%PDD4.6%BEKE3.9%CTKB3.5%ALMR3.1%BABA2.1%ODTX1.9%YSG1.9%NBP1.4%CTNM1.3%21 more7.9%

The 14 largest of its 35 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.

Reported holdings, quarter by quarter
Q3 2024: $4.56 billion in 48 positions$4.56BQ3 24Q4 2024: $2.89 billion in 45 positions$2.89BQ4 24Q1 2025: $3.54 billion in 49 positions$3.54BQ1 25Q2 2025: $3.10 billion in 36 positions$3.10BQ2 25Q3 2025: $4.09 billion in 33 positions$4.09BQ3 25Q4 2025: $3.10 billion in 33 positions$3.10BQ4 25Q1 2026: $1.67 billion in 38 positions$1.67BQ1 26Q2 2026: $832.1 million in 35 positions$832MQ2 26

What the fund reported holding at each quarter's end; hover a bar for the number of positions

What its reported holdings returned

Held through each quarter, the holdings it reported returned -10.7% over the 7 quarters to 30 June 2026, against +30.2% for the S&P 500.

Its reported holdingsThe S&P 500
90105120135Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Its holdings -10.7%S&P 500 +30.2%

Not the fund's own return: each 13F's holdings are kept unchanged until the next one, so trades inside a quarter, dividends, cash and fees are left out. A rough guide to how its picks have done over time.

What it did on the quarter

Opened 6Added 6Held 17Trimmed 6Sold out 9
Opened: 6Added: 6Held: 17Trimmed: 6Sold out: 9

Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held

Opened 6

  1. Alamar Biosciences Inc. ALMR$25.9 million
  2. Odyssey Therapeutics, Inc. ODTX$15.6 million
  3. NetEase, Inc. NTES$4.5 million
  4. Texas Instruments Inc. TXN$1.4 million
  5. Zoom Video Communications in ZM$777,653
  6. Ridgetech Inc. SHS New RDGT$204

Added to 6

  1. Vipshop Hldgs Ltd VIPS+3.3 million shares · +2683%
  2. Futu Hldgs Ltd FUTU+348,800 shares · +25%
  3. Lumentum Holdings Inc. LITE+1,800 shares · +120%
  4. NVIDIA Corp. NVDA+7,444 shares · +113%
  5. Coherent Corp. COHR+2,142 shares · +50%
  6. Corning Inc. GLW+2,566 shares · +33%

Trimmed 6

  1. PDD Holdings Inc. PDD-3.7 million shares · -88%
  2. Alibaba Group Holding Limited BABA-2.3 million shares · -93%
  3. KE Holdings Inc. BEKE-2.0 million shares · -48%
  4. Webull Corp. BULL-1.2 million shares · -79%
  5. Marvell Technology, Inc. MRVL-8,100 shares · -5%
  6. Intel Corp. INTC-14,670 shares · -51%

Sold out of 9

  1. Beigene, Ltd ONC$307.2 million last quarter
  2. Clearwater Analytics Hldgs I CWAN$32.3 million last quarter
  3. Barrick Mining Corp B$1.0 million last quarter
  4. Dingdong Cayman Ltd DDL$911,065 last quarter
  5. Centrais Eletricas Brasileir AXIAY$711,768 last quarter
  6. iShares Inc. EWW$662,024 last quarter
  7. 21VIANET Group Inc. VNET$546,189 last quarter
  8. Uxin Ltd UXIN$58,809 last quarter

What it holds

CompanySharesValueOf its bookChange in shares
Legend Biotech Corp. LEGN6.0M$172.8 million20.77%no change
Futu Hldgs Ltd FUTU1.8M$165.8 million19.92%+348.8K
Arrivent Biopharma Inc. AVBP3.9M$136.5 million16.40%no change
Marvell Technology, Inc. MRVL162.9K$48.5 million5.83%-8.1K
Vipshop Hldgs Ltd VIPS3.5M$46.0 million5.53%+3.3M
PDD Holdings Inc. PDD500.0K$38.1 million4.58%-3.7M
KE Holdings Inc. BEKE2.2M$32.2 million3.87%-2.0M
Cytek Biosciences Inc. CTKB6.7M$29.5 million3.54%no change
Alamar Biosciences Inc. ALMR956.5K$25.9 million3.11%new
Alibaba Group Holding Limited BABA183.9K$17.7 million2.12%-2.3M
Odyssey Therapeutics, Inc. ODTX831.7K$15.6 million1.87%new
Yatsen Hldg Ltd YSG4.9M$15.5 million1.86%no change
I Mab NBP6.0M$11.7 million1.40%no change
Contineum Therapeutics Inc. CTNM669.3K$11.0 million1.32%no change
Maze Therapeatics MAZE366.0K$10.9 million1.31%no change
Agora Inc. API2.1M$8.4 million1.01%no change
Taiwan Semiconductor Manufacturing Company Limited TSM15.5K$7.4 million0.89%-10
Sagimet Biosciences Inc. SGMT724.8K$5.6 million0.67%no change
NetEase, Inc. NTES35.0K$4.5 million0.54%new
General Electric Co. GE10.0K$3.8 million0.45%no change
Lumentum Holdings Inc. LITE3.3K$2.8 million0.34%+1.8K
NVIDIA Corp. NVDA14.1K$2.8 million0.34%+7.4K
Tuya Inc. TUYA1.6M$2.8 million0.33%no change
Corning Inc. GLW10.3K$2.6 million0.32%+2.6K
Coherent Corp. COHR6.4K$2.5 million0.30%+2.1K
Webull Corp. BULL309.9K$2.0 million0.24%-1.2M
Intel Corp. INTC14.3K$2.0 million0.24%-14.7K
Pacific Biosciences Calif in PACB918.9K$1.5 million0.19%no change
Texas Instruments Inc. TXN4.8K$1.4 million0.17%new
Mogu Inc. MOGU847.5K$1.4 million0.17%no change
Gossamer Bio Inc. GOSS5.0M$818,7270.10%no change
Equinox Gold Corp. EQX80.5K$782,4600.09%no change
Zoom Video Communications in ZM9.0K$777,6530.09%new
Aligos Therapeutics Inc. ALGS76.2K$439,9450.05%no change
Ridgetech Inc. SHS New RDGT136$2040.00%new
Every US-listed position in the fund's 13F for the quarter ended 30 June 2026, by the value it reported.
Read moreChange is shares against its 13F for the quarter before; the 9 it sold out of are in the box above.